Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Journal of the American College of Cardiology|July 13, 2010
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysisJean-Sébastien Hulot, Jean-Philippe Collet, Johanne Silvain, et al.Current Medical Research and Opinion|May 27, 2022
Physician preferences for attributes of pediatric combination vaccines in the United StatesSalome Samant, Tanaz Petigara, Jyoti Aggarwal, et al.Nephrologie & Therapeutique|October 11, 2021
[A rare presentation of kidney allograft intolerance syndrome: Bullous pemphigoid]Rui Barata, Nuno Moreira Fonseca, Tiago Assis Pereira, et al.Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|June 7, 2025
Outcomes of reversal of malabsorptive and maldigestive bariatric procedures: a single center experience and a systematic reviewPauline Aeschbacher, Angelica Garcia, Joel Frieder, et al.Journal of Medicinal Chemistry|February 16, 2007
Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8Ana Pena, Brigitte Murat, Miguel Trueba, et al.Circulation|September 4, 2008
Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) studyJean-Philippe Collet, Johanne Silvain, Antoine Landivier, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|September 1, 2005
Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivityGilles Guillon, Ana Pena, Brigitte Murat, et al.European Heart Journal|July 2, 2010
Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION studyJohanne Silvain, Ana Pena, Guillaume Cayla, et al.Journal of the American College of Cardiology|February 23, 2010
Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside testJohanne Silvain, Farzin Beygui, Annick Ankri, et al.Circulation|March 16, 2011
Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysisYacine Boulaftali, Benoit Ho-Tin-Noe, Ana Pena, et al.Pageof 3